Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Revisiting Human IL-12R beta 1 Deficiency A Survey of 141 Patients From 30 Countries MEDICINE de Beaucoudrey, L., Samarina, A., Bustamante, J., Cobat, A., Boisson-Dupuis, S., Feinberg, J., Al-Muhsen, S., Janniere, L., Rose, Y., de Suremain, M., Kong, X., Filipe-Santos, O., Chapgier, A., Picard, C., Fischer, A., Dogu, F., Ikinciogullari, A., Tanir, G., Al-Hajjar, S., Al-Jumaah, S., Frayha, H. H., Alsum, Z., Al-Ajaji, S., Alangari, A., Al-Ghonaium, A., Adimi, P., Mansouri, D., Ben-Mustapha, I., Yancoski, J., Garty, B., Rodriguez-Gallego, C., Caragol, I., Kutukculer, N., Kumararatne, D. S., Patel, S., Doffinger, R., Exley, A., Jeppsson, O., Reichenbach, J., Nadal, D., Boyko, Y., Pietrucha, B., Anderson, S., Levin, M., Schandene, L., Schepers, K., Efira, A., Mascart, F., Matsuoka, M., Sakai, T., Siegrist, C., Frecerova, K., Blueetters-Sawatzki, R., Bernhoeft, J., Freihorst, J., Baumann, U., Richter, D., Haerynck, F., De Baets, F., Novelli, V., Lammas, D., Vermylen, C., Tuerlinckx, D., Nieuwhof, C., Pac, M., Haas, W. H., Mueller-Fleckenstein, I., Fleckenstein, B., Levy, J., Raj, R., Cohen, A. C., Lewis, D. B., Holland, S. M., Yang, K. D., Wang, X., Wang, X., Jiang, L., Yang, X., Zhu, C., Xie, Y., Lee, P. P., Chan, K. W., Chen, T., Castro, G., Natera, I., Codoceo, A., King, A., Bezrodnik, L., Di Giovani, D., Isabel Gaillard, M., de Moraes-Vasconcelos, D., Grumach, A. S., da Silva Duarte, A. J., Aldana, R., Javier Espinosa-Rosales, F., Bejaoui, M., Bousfiha, A. A., El Baghdadi, J., Ozbek, N., Aksu, G., Keser, M., Somer, A., Hatipoglu, N., Aydogmus, C., Asilsoy, S., Camcioglu, Y., Gulle, S., Ozgur, T. T., Ozen, M., Oleastro, M., Bernasconi, A., Mamishi, S., Parvaneh, N., Rosenzweig, S., Barbouche, R., Pedraza, S., Lau, Y. L., Ehlayel, M. S., Fieschi, C., Abel, L., Sanal, O., Casanova, J. 2010; 89 (6): 381-402

Abstract

Interleukin-12 receptor ß1 (IL-12Rß1) deficiency is the most common form of Mendelian susceptibility to mycobacterial disease (MSMD). We undertook an international survey of 141 patients from 102 kindreds in 30 countries. Among 102 probands, the first infection occurred at a mean age of 2.4 years. In 78 patients, this infection was caused by Bacille Calmette-Guérin (BCG; n = 65), environmental mycobacteria (EM; also known as atypical or nontuberculous mycobacteria) (n = 9) or Mycobacterium tuberculosis (n = 4). Twenty-two of the remaining 24 probands initially presented with nontyphoidal, extraintestinal salmonellosis. Twenty of the 29 genetically affected sibs displayed clinical signs (69%); however 8 remained asymptomatic (27%). Nine nongenotyped sibs with symptoms died. Recurrent BCG infection was diagnosed in 15 cases, recurrent EM in 3 cases, recurrent salmonellosis in 22 patients. Ninety of the 132 symptomatic patients had infections with a single microorganism. Multiple infections were diagnosed in 40 cases, with combined mycobacteriosis and salmonellosis in 36 individuals. BCG disease strongly protected against subsequent EM disease (p = 0.00008). Various other infectious diseases occurred, albeit each rarely, yet candidiasis was reported in 33 of the patients (23%). Ninety-nine patients (70%) survived, with a mean age at last follow-up visit of 12.7 years ± 9.8 years (range, 0.5-46.4 yr). IL-12Rß1 deficiency is characterized by childhood-onset mycobacteriosis and salmonellosis, rare recurrences of mycobacterial disease, and more frequent recurrence of salmonellosis. The condition has higher clinical penetrance, broader susceptibility to infections, and less favorable outcome than previously thought.

View details for DOI 10.1097/MD.0b013e3181fdd832

View details for Web of Science ID 000283840300002

View details for PubMedID 21057261

View details for PubMedCentralID PMC3129625